U.S. patent number 3,874,852 [Application Number 05/485,931] was granted by the patent office on 1975-04-01 for reagent and method for determining leukocytes and hemoglobin in the blood.
This patent grant is currently assigned to Coulter Diagnostics, Inc.. Invention is credited to Thomas E. Hamill.
United States Patent |
3,874,852 |
Hamill |
April 1, 1975 |
**Please see images for:
( Reexamination Certificate ) ** |
REAGENT AND METHOD FOR DETERMINING LEUKOCYTES AND HEMOGLOBIN IN THE
BLOOD
Abstract
Leukocytes and hemoglobin in the blood are determined in vitro
with a reagent which comprises a ferricyanide ion-free aqueous
solution containing a quaternary ammonium ion and cyanide ion in
amounts sufficient to stromatolyse erythrocyte and platelet cells
and to convert hemoglobin to a chromogen for the
determinations.
Inventors: |
Hamill; Thomas E. (Fort
Lauderdale, FL) |
Assignee: |
Coulter Diagnostics, Inc.
(Hialeah, FL)
|
Family
ID: |
23929974 |
Appl.
No.: |
05/485,931 |
Filed: |
July 5, 1974 |
Current U.S.
Class: |
436/63; 436/17;
436/10; 436/66 |
Current CPC
Class: |
G01N
33/721 (20130101); G01N 33/5094 (20130101); Y10T
436/107497 (20150115); Y10T 436/101666 (20150115) |
Current International
Class: |
G01N
33/72 (20060101); G01N 33/72 (20060101); G01N
33/50 (20060101); G01N 33/50 (20060101); G01n
033/16 () |
Field of
Search: |
;23/23B ;252/408 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Serwin; R. E.
Attorney, Agent or Firm: Silverman & Cass, Ltd.
Claims
What is claimed is:
1. A reagent for use in the determination of leukocytes and
hemoglobin in the blood, which comprises a ferricyanide ion-free
aqueous solution containing a quaternary ammonium ion and cyanide
ion, said quaternary ammonium ion having attached to nitrogen three
short chain alkyl groups and one long chain alkyl group, and said
ions being present in amounts sufficient to stromatolyse
erythrocyte and platelet cells and to convert hemoglobin to a
chromogen for said determinations.
2. A reagent according to claim 1 wherein said quaternary ammonium
ion is provided by a quaternary ammonium salt incorporated in said
solution in a concentration in the range of about 0.5 to 10 percent
by weight of said solution, and said cyanide ion is present in a
concentration in the range of about 0.0006 to 0.005 molar.
3. A reagent according to claim 2 wherein said salt is a trimethyl
tetradecyl ammonium halide, sulfate, phosphate, or nitrate, and
said cyanide ion is provided by an alkali metal cyanide
incorporated in said solution.
4. A reagent according to claim 1 wherein said short chain alkyl
groups each have from 1 to 3 carbon atoms and said long chain alkyl
group has from 10 to 14 carbon atoms.
5. A reagent according to claim 4 wherein said quaternary ammonium
ion is provided by a quaternary ammonium salt incorporated in said
solution in a concentration in the range of about 0.5 to 10 percent
by weight of said solution, and said cyanide ion is provided by an
alkali metal cyanide incorporated in said solution in a
concentration in the range of about 0.0006 to 0.005 molar.
6. A reagent according to claim 5 wherein said salt is a halide,
sulfate, phosphate, or nitrate.
7. A reagent according to claim 1 comprising a composition having
the following ingredients and relative proportions:
8. In a method of determining leukocytes and hemoglobin in the
blood wherein a reagent is reacted with a blood sample to
stromatolyse erythrocyte and platelet cells and to convert
hemoglobin to a chromogen for said determinations, the improvement
which comprises employing as said reagent a ferricyanide ion-free
aqueous solution containing a quaternary ammonium ion and cyanide
ion, said quaternary ammonium ion having attached to nitrogen three
short chain alkyl groups and one long chain alkyl group.
Description
BACKGROUND OF THE INVENTION
This invention relates to a reagent and a method for determining
leukocytes and hemoglobin in the blood. More particularly, the
invention relates to an in vitro diagnostic reagent for high speed
erythrocyte stromatolysing with rapid conversion of hemoglobin to a
chromogen, for use in the determination of leukocytes and
hemoglobin in the blood.
The introduction of high speed automated hematology instruments
such as the Coulter Counter Model S has resulted in a need for high
speed erythrocyte-stromatolysing and chromogen-forming reagents
which give a clear, stable, reproducible solution whose optical
density is directly proportional to the hemoglobin concentration.
In an instrument of this type, blood is mixed with a conventional
diluent, to provide a first dilution, and then mixed with a lysing
agent, to provide a second dilution. The respective first and
second dilutions may be, for example, 224:1 and 250:1. The mixture
remains in the lysing chamber for a short but sufficient amount of
time for the erythrocytes or red blood cells to be disintegrated
and release their hemoglobin. The resulting suspension is passed
into tubes in a leukocyte aperture counting bath, wherein the
leukocytes or white blood cells are counted electronically. With
the released hemoglobin contained in the leukocyte count
suspension, the hemoglobin concentration is determined
spectrophotometrically in the same bath. Inasmuch as the ratio of
erythrocytes to leukocytes in normal blood is in the vicinity of
1000:1, the erythrocytes must be reduced rapidly to very small
fragments, to avoid interference with leukocyte counting. At the
same time, leukocytes must not be destroyed, and it is necessary to
convert hemoglobin to a form suitable for accurate photometric
determination.
Heretofore, lysing and cyanmethemoglobin chromogenforming reagents
have been used in automated high speed hematology equipment.
However, these reagents have been found to be unsatisfactory as
respects their stability.
It has been known also that a quaternary ammonium salt
advantageously is employed as a stromatolysing agent, with the
virtually instantaneous destruction of erythrocytes to a level
avoiding interference with leukocyte estimation, and providing a
relatively stable reagent (see, for example, The Americam Journal
of Clinical Pathology, Vol. 36, No. 3, Pages 220-223, Sept., 1961).
The quaternary ammonium ion in the salt is of the type having three
short chain alkyl groups and one long chain alkyl group attached to
nitrogen.
The standard method of determining hemoglobin embodies the use of
Drabkin's reagent, which contains potassium ferricyanide, potassium
cyanide, and sodium bicarbonate. When hemoglobin is added to this
reagent, the potassium ferricyanide is reduced to potassium
ferrocyanide, and the hemoglobin is oxidized to methemoglobin. The
latter reacts with the cyanide ion to produce the stable chromogen,
cyanmethemoglobin, which may be measured photometrically. Drabkin's
reagent is not stable upon exposure to freezing temperatures.
Ferricyanide ion has a tendency to form insoluble complexes with
quaternary ammonium compounds. Thus, a mixture of the prior
quaternary ammonium compound reagent with Drabkin's reagent may be
unreliable, since in the event of precipitation, the precipitate,
no matter how slight, would falsely raise the leukocyte count.
It would be desirable to provide an accurate, stable high speed
stromatolysing and chromogen-forming reagent for use in high speed
automated hematology instruments. It would be preferable to provide
a reagent which also is not adversely affected by exposure to
freezing temperatures.
SUMMARY OF THE INVENTION
The reagent of the invention comprises a ferricyanide ion-free
aqueous solution containing a quaternary ammonium ion and cyanide
ion, the quaternary ammonium ion having attached to nitrogen three
short chain alkyl groups and one long chain alkyl group, and said
ions being present in amounts sufficient to stromatolyse
erythrocyte and platelet cells in the blood and to convert
hemoglobin to a chromogen for leukocyte and hemoglobin
determinations. In the method of the invention, the foregoing
reagent is reacted with a blood sample for the determination of
leukocytes and hemoglobin in the blood.
The reagent of the invention is a stable composition that provides
leukocyte and hemoglobin determinations with the necessary
diagnostic accuracy. More particularly, the reagent reduces
erythrocytes to very small fragments within a short period of time,
without destroying leukocytes. The reagent forms no precipitate
which would interfere with leukocyte determination.
The reagent converts hemoglobin to a stable chromogen having
spectral characteristics resembling cyanmethemoglobin, which is
suitable for photometric analysis with a high degree of accuracy: A
clear, stable and reproducible solution is provided for analysis,
the optical density of which is directly proportional to the
hemoglobin concentration.
The invention embodies the discovery that ferricyanide ion need not
be employed, and only cyanide ion need be employed together with a
quaternary ammonium ion to convert hemoglobin to a stable chromogen
suitable for analysis. Consequently, there is no risk of complex
formation caused by the presence of ferricyanide ion. The reagent
is a colorless solution.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The reagent of the invention is an aqueous solution free of
ferricyanide ion and containing as the active ions a quaternary
ammonium ion and cyanide ion. Each of the respective ions may be
provided in the form of a suitable salt with an ion of opposite
sign. The quaternary ammonium ion preferably is supplied in the
form of a salt with an inorganic anion, especially as a halide,
such as chloride or bromide, a sulfate, a phosphate, or a nitrate.
The cyanide ion preferably is supplied in the form of a salt with
an inorganic cation, especially an alkali metal cation such as
sodium or potassium. The solution may consist essentially of such
salts dissolved in water.
In general, the quaternary ammonium ion is of the type previously
employed in the art as a stromatolysing agent, i.e., having
attached to nitrogen three short chain alkyl groups and one long
chain alkyl group. For convenience, the short chain alkyl groups
will be referred to hereinafter at times by the symbols R.sub.1,
R.sub.2, and R.sub.3, and the long chain alkyl group will be
referred to as R.sub.4. Generally speaking, R.sub.1, R.sub.2,
and/or R.sub.3 may have from 1 to 4 carbon atoms, as represented by
methyl, ethyl, propyl, and butyl radicals. R.sub.4 may vary in the
range of about 10 to 20 carbon atoms, ranging from decyl to
eicosyl.
The quaternary ammonium ion is provided by a quaternary ammonium
salt incorporated in aqueous solution in a concentration within the
overall range of about 0.5 to 10 percent, preferably about 1-5
percent, by weight of the solution. A solution of such
concentration is employed as the lysing agent, and is mixed with
blood previously diluted with standard diluent, in a ratio of about
1:8.6, lysing agent to dilute sample, as described above. It will
be understood that different strength lysing agent may be employed
where the initial dilution of the blood sample differs from that
described above, in order to provide the same ultimate
concentration of reactive ion.
The specific quaternary amomonium ion and its concentration are
selected to provide the necessary hemolytic activity and solubility
of the quaternary ammonium compound. In general, with increasing
number of carbon atoms, the solubility of the compound decreases,
and with increasing number of R.sub.4 carbon atoms, the hemolytic
activity increases. Thus, for example, where R.sub.1, R.sub.2 and
R.sub.3 are methyl, R.sub.4 may include from about 10 to 20 carbon
atoms (C.sub.10 to C.sub.20) to provide sufficient hemolytic
activity at a concentration of 5% when employed in the
above-described analytical method. At a concentration of about 0.5
percent and where R.sub.1, R.sub.2 and R.sub.3 are methyl, R.sub.4
should have at least about 14 carbon atoms to provide the necessary
hemolytic activity. At a concentration of about 10 percent and
where R.sub.1, R.sub.2 and R.sub.3 are methyl, R.sub.4 should have
a maximum of about 16 carbon atoms, to provide the necessary
solubility for the compound. As additional examples, where R.sub.4
is tetradecyl, R.sub.1, R.sub.2, and R.sub.3 may be methyl, ethyl,
or propyl radicals at 0.5 to 10 percent concentration, while
providing sufficient hemolytic activity and a complete solution.
Where R.sub.4 is tetradecyl and R.sub.1 is methyl, R.sub.2 is
methyl or ethyl, and R.sub.3 is butyl, the hemolytic activity is
sufficient and the compound is soluble at 0.5 to 5 percent, but the
compound is incompletely soluble at a concentration of 10
percent.
It is a feature of the invention that the reagent may be compounded
to allow for freezing and thawing of the solution without formation
of excessive particulate matter, i.e., such as would exceed the
accuracy of the instrument and interfere with an accurate leukocyte
count. The above-identified instrument has an accuracy limit of
about 200 cells. For example, when R.sub.4 is decyl, dodecyl, or
tetradecyl, and R.sub.1, R.sub.2, and R.sub.3 are methyl, a
solution of 5 percent concentration may be frozen and thawed with
resulting formation of less than 200 particles in 0.5 ml., as
determined using the Coulter Counter F.sub.N at red blood cell
threshold settings. Where R.sub.4 is tetradecyl and R.sub.1,
R.sub.2, and R.sub.3 are from methyl to propyl, a solution of 5
percent concentration may be frozen and thawed with resulting
particle count of less than 200. On the other hand, where R.sub.4
is from C.sub.16 to C.sub.20, and R.sub.1, R.sub.2 and R.sub.3 are
methyl, the particle count exceeds 200 after freezing and thawing a
solution of 5% concentration. Likewise, where R.sub.4 is
tetradecyl, R.sub.1 is methyl, R.sub.2 is methyl or ethyl, and
R.sub.3 is butyl, the particle count exceeds 200 after freezing and
thawing a solution of 5% concentration. Accordingly, it is
preferred that R.sub.1, R.sub.2 and R.sub.3 each have from 1 to 3
carbon atoms, and that R.sub.4 have from 10 to 14 carbon atoms.
The concentration of cyanide ion preferably is selected to provide
at least about 89 percent conversion of hemoglobin to a chromogen.
Thus, for example, in providing a solution for use in the
above-described manner, the cyanide ion preferably is present in a
concentration in the range of about 0.0006 to 0.005 molar, and
preferably in excess of about 0.001 molar. A salt furnishing the
cyanide ion is employed in a molarity to provide the desired
cyanide ion concentration, being the same molarity in the case of a
salt with a monovalent cation such as an alkali metal. Conversions
to a chromogen of up to about 96% of the hemoglobin may be
obtained. The chromogen is analyzed spectrophotometrically at 540
nanometers.
The following is a specific example of a reagent according to the
invention. It will be understood that the example is only
illustrative, and various other ingredients and proportions may be
employed, in accordance with the preceeding disclosure.
EXAMPLE
The following composition may be employed as a lysing and
chromogen-forming reagent in the Coulter Counter Model S, following
the procedure described hereinabove:
Ingredient Proportion ______________________________________ Water
1 liter Potassium cyanide 0.25 gram (0.00385M) Trimethyl tetradecyl
ammonium chloride 35 grams (3.38%)
______________________________________
The composition has a pH of approximately 9. When employed for
analysis with the commercial buffered blood diluent Isoton and
following said procedure, the pH of the final solution is
approximately 7.6.
* * * * *